Independent Predictors of Mortality Among Patients With NAFLD Hospitalized With COVID‐19 Infection
The impact of the coronavirus disease 2019 (COVID‐19) pandemic among patients with chronic liver disease is unknown. Given the high prevalence of nonalcoholic fatty liver disease (NAFLD), we determined the predictors of mortality and hospital resource use among patients with NAFLD admitted with COVI...
Main Authors: | , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Health/LWW
2022-11-01
|
Series: | Hepatology Communications |
Online Access: | https://doi.org/10.1002/hep4.1802 |